Common Contracts
4 similar Underwriting Agreement contracts by New York Mortgage Trust Inc, Repros Therapeutics Inc.
NEW YORK MORTGAGE TRUST, INC. 2,750,000 Shares of Common Stock* UNDERWRITING AGREEMENTUnderwriting Agreement • May 31st, 2012 • New York Mortgage Trust Inc • Real estate investment trusts • New York
New York Mortgage Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, subject to the conditions hereinafter stated, to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) an aggregate of 2,750,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (“Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (this “Agreement”) in connection with the public offering (the “Offering”) and sale of such Firm Securities.
NEW YORK MORTGAGE TRUST, INC. 1,500,000 Shares of Common Stock* UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2011 • New York Mortgage Trust Inc • Real estate investment trusts • New York
New York Mortgage Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, subject to the conditions hereinafter stated, to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) an aggregate of 1,500,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (“Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (this “Agreement”) in connection with the public offering (the “Offering”) and sale of such Firm Securities.
690,000 Units REPROS THERAPEUTICS INC. Each Unit consisting of 4 Shares of Common Stock and 3 Series A Warrants and 2.45 Series B Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • February 9th, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Based on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:
] Units REPROS THERAPEUTICS INC. Each Unit consisting of [ ] Shares of Common Stock and [ ] Series A Warrants and [ ] Series B Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Based on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:
